FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
cobas HCV
K Number: K252484
·
Decision Nov 3, 2025
Classifications
1
FEI Numbers
9
Registration Numbers
9
Same Product Code
3
Applicant Total
51
Review Days
88
Basic Information
- Device Name
- cobas HCV
- K Number
- K252484
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3170
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Roche Molecular Systems, Inc.
- Date Received
- August 7, 2025
- Decision Date
- November 3, 2025
- Product Code
- MZP
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MZP | Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MZP), ordered by most recent decision date.
Alinity m HCV
FDA 510(k)
FDA Class 2
·Microbiology
Aptima HCV Quant Dx Assay
FDA 510(k)
FDA Class 2
·Microbiology
cobas HCV
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Roche Molecular Systems, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K253756 | cobas liat CT/NG nucleic acid test | May 15, 2026 | Substantially Equivalent |
| K253759 | cobas liat CT/NG/MG nucleic acid test | May 15, 2026 | Substantially Equivalent |
| K243753 | cobas liat Bordetella panel nucleic acid test | Nov 20, 2025 | Substantially Equivalent |
| K252481 | cobas CMV | Nov 3, 2025 | Substantially Equivalent |
| K243455 | cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems | Jul 31, 2025 | Substantially Equivalent |
| K243863 | Opulus Lymphoma Precision | May 30, 2025 | Substantially Equivalent |
| K243400 | cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test | Apr 25, 2025 | Substantially Equivalent |
| K243406 | cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test | Apr 25, 2025 | Substantially Equivalent |
| K243346 | cobas liat SARS-CoV-2 v2 nucleic acid test | Apr 11, 2025 | Substantially Equivalent |
| K240867 | cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems | Feb 11, 2025 | Substantially Equivalent |